Drug Database
Back to search

France· FR:65356777

OCTREOTIDE TEVA LP 10 mg, poudre et solvant pour suspension injectable à libération prolongée

A octreotide product containing acétate d'octréotide, registered in France by TEVA (PAYS-BAS), on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC H01CB02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedOCTREOTIDE TEVA LP 10 mg, poudre et s…ATCH01CB02REGISTER NO.FR:65356777PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about acétate d'octréotideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Octreotide is registered in 17 of 19 countries.

Countries holding a registration under ATC H01CB02 (octreotide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose
Search octreotide products by name

Octreotide · ATC H01CB02

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of octreotide costs, country by country.

Normalised to the WHO defined daily dose (0.7 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Octreotide · price per daily dose (0.7 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$41.46
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ACÉTATE D'OCTRÉOTIDE
Manufacturer
TEVA (PAYS-BAS)
Country
France (FR)
ATC code
H01CB02
ATC class
Octreotide
Defined daily dose
0.7 mg, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930180525
    1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre de 2 ml avec adaptateur avec aiguille(s) sécurisée(s)
    EUR 348.57

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

367 interactions on record for octreotide.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check octreotide against other medicinesHow interaction checks work

Octreotide · interactions on record

367 records

  • 4 severe
  • 151 moderate
  • 4 minor
  • 168 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • PexidartinibL01EX15severe
  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe

40 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Octreotide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All octreotide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Octreotide Ratiopharm, Sandostatin
  • Belgium · Octreoteva Long Acting, Octreotide Qilu
  • Bulgaria · Octreotid Lyomark, Октреотид Lai Тева
  • Cyprus · Octreotide Rompharm, Sandostatin
  • Czechia · Octreotide Teva, Octreotide Teva B.V.
  • Germany · Octreo Ratiopharm, Octreotid Bendalis
  • Denmark · Octreoanne, Octreotid Sun
  • Estonia · Octreotide Teva, Sandostatin
  • Spain · Octreotida Gp-Pharm, Octreotida Sun
  • Finland · Octreotide Orion, Octreotide Ratiopharm
  • United Kingdom (Northern Ireland) · Octreotide Chemi, Octreotide Hospira Uk
  • Greece · Okrodin, Sandostatin
  • Croatia · Oktreotid Teva, Sandostatin
  • Hungary · Oktreotid Teva, Sandostatin
  • Ireland · Octreotide Pfizer Healthcare Ireland, Olatuton
  • Iceland · Octreoanne, Oczyesa
  • Italy · Octreotide Bioindustria L.I.M., Octreotide Sun
  • Liechtenstein · Oczyesa
  • Lithuania · Octreotide Teva, Sandostatin
  • Luxembourg · Octreoteva Long Acting, Sandostatine
  • Latvia · Sandostatin, Sandostatin Lar
  • Malta · Sandostatin, Sandostatin Lar
  • Netherlands · Octreotide Bendalis, Octreotide Depot Teva
  • Norway · Octreoanne, Octreotide Orion
  • Poland · Okteva, Sandostatin
  • Portugal · Octreotido Color, Octreotido Depot Teva
  • Romania · Octreotidă Rompharm, Octreotidă Teva
  • Sweden · Octreotide Orion, Octreotide Teva
  • Slovenia · Oktreotid Teva, Sandostatin
  • Slovakia · Sandostatin, Sandostatin Lar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7b07cf3a-739c-456c-bca8-71ee14767139
GET /v1/drugs/7b07cf3a-739c-456c-bca8-71ee14767139?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65356777",
  "date_amm": "2019-06-27",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "ACÉTATE D'OCTRÉOTIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre et  solvant pour suspension injectable à libération prolongée",
  "voies_administration": "intramusculaire",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about octreotide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console